WSE:MRC

Stock Analysis Report

Executive Summary

Mercator Medical S.A., together with its subsidiaries, produces medical gloves and distributes medical disposables in Europe and Russia.

Snowflake

Fundamentals

Mediocre balance sheet and overvalued.

Share Price & News

How has Mercator Medical's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

22.5%

MRC

-0.2%

PL Medical Equipment

1.9%

PL Market


1 Year Return

-50.6%

MRC

-12.7%

PL Medical Equipment

0.2%

PL Market

Return vs Industry: MRC underperformed the Polish Medical Equipment industry which returned -12.7% over the past year.

Return vs Market: MRC underperformed the Polish Market which returned 0.2% over the past year.


Shareholder returns

MRCIndustryMarket
7 Day22.5%-0.2%1.9%
30 Day15.3%0.6%0.5%
90 Day-2.5%-8.9%-5.7%
1 Year-50.6%-50.6%-12.7%-12.7%3.3%0.2%
3 Year-59.0%-59.3%-78.7%-78.9%12.3%4.3%
5 Year-36.7%-38.0%-77.2%-80.5%0.2%-12.0%

Price Volatility Vs. Market

How volatile is Mercator Medical's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Mercator Medical undervalued compared to its fair value and its price relative to the market?

0.57x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate MRC's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate MRC's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: MRC is unprofitable, so we can't compare its PE Ratio to the Medical Equipment industry average.

PE vs Market: MRC is unprofitable, so we can't compare its PE Ratio to the Polish market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate MRC's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: MRC is good value based on its PB Ratio (0.6x) compared to the PL Medical Equipment industry average (0.8x).


Next Steps

Future Growth

How is Mercator Medical forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

29.6%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: MRC is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: MRC is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: MRC is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: Insufficient data to determine if MRC's revenue is forecast to grow faster than the Polish market.

High Growth Revenue: Insufficient data to determine if MRC's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if MRC's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Mercator Medical performed over the past 5 years?

-14.9%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: MRC is unprofitable, and losses have increased over the past 5 years at a rate of -14.9% per year.

Accelerating Growth: Unable to compare MRC's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MRC is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (5.5%).


Return on Equity

High ROE: MRC has a negative Return on Equity (-0.93%), as it is currently unprofitable.


Return on Assets

ROA vs Industry: MRC is currently unprofitable, so its Return on Assets is negative.


Return on Capital Employed

ROCE Improving: MRC is currently unprofitable, so its Return on Capital Employed is negative.


Next Steps

Financial Health

How is Mercator Medical's financial position?


Financial Position Analysis

Short Term Liabilities: MRC's short term assets (PLN174.5M) exceeds its short term liabilities (PLN146.9M)

Long Term Liabilities: MRC's short term assets (174.5M) exceeds its long term liabilities (89.3M)


Debt to Equity History and Analysis

Debt Level: MRC's debt to equity ratio (102.7%) is considered high

Reducing Debt: MRC's debt to equity ratio has increased from 35.9% to 102.7% over the past 5 years.

Debt Coverage: MRC's debt is well covered by operating cash flow (32.5%).

Interest Coverage: MRC is unprofitable, therefore interest payments are not well covered by earnings.


Balance Sheet

Inventory Level: MRC has a high level of physical assets or inventory.

Debt Coverage by Assets: MRC's debt is covered by short term assets (assets are 1.311740x debt).


Next Steps

Dividend

What is Mercator Medical's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

company0%marketbottom25%2.7%markettop25%7.2%industryaverage1.5%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate MRC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate MRC's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if MRC's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if MRC's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: MRC is not paying a notable dividend for the Polish market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of MRC's dividend in 3 years as they are not forecast to pay a notable one for the Polish market.


Next Steps

Management

What is the CEO of Mercator Medical's salary, the management and board of directors tenure and is there insider trading?

5.2yrs

Average management tenure


CEO

Wieslaw Zyznowski (55yo)

9.8yrs

Tenure

zł480,000

Compensation

Dr. Wieslaw Zyznowski has been the Chairman of Management Board at Mercator Medical Spólka Akcyjna since 2010. In the 90s Dr. Zyznowski co-founded the Mercator. From 1991 to 2001 he served as (apart from a ...


CEO Compensation Analysis

Compensation vs. Market: Wieslaw's total compensation ($USD0.00) is too low to compare against companies of similar size in the Polish market ($USD0.00).

Compensation vs Earnings: Wieslaw's compensation has increased whilst the company is unprofitable.


Management Age and Tenure

5.2yrs

Average Tenure

55yo

Average Age

Experienced Management: MRC's management team is seasoned and experienced (5.2 years average tenure).


Board Age and Tenure

6.2yrs

Average Tenure

50yo

Average Age

Experienced Board: MRC's board of directors are considered experienced (6.2 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown


Management Team

  • Witold Kruszewski

    CFO & Member of Management Board

    • Tenure: 3.9yrs
    • Compensation: zł360.00k
  • Wieslaw Zyznowski (55yo)

    Chairman of Management Board

    • Tenure: 9.8yrs
    • Compensation: zł480.00k
  • Leszek Michnowski (58yo)

    Vice President of the Management Board

    • Tenure: 6.5yrs
    • Compensation: zł397.10k
  • Monika Durakiewicz (33yo)

    Member of the Management Board

    • Tenure: 2.1yrs
    • Compensation: zł46.60k
  • Monika Zyznowska

    Board Member

    • Tenure: 0yrs

Board Members

  • Jaroslaw Karasinski (52yo)

    Member of Supervisory Board

    • Tenure: 5.3yrs
  • Urszula Zyznowska (48yo)

    Chairwoman of Supervisory Board

    • Tenure: 9.8yrs
  • Piotr Solorz (48yo)

    Vice Chairman of Supervisory Board

    • Tenure: 0yrs
  • Marian Slowiaczek (69yo)

    Member of Supervisory Board

    • Tenure: 6.2yrs
  • Gabriela Stolarczyk-Zadecka (50yo)

    Member of the Supervisory Board

    • Tenure: 0yrs

Company Information

Mercator Medical S.A.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Mercator Medical S.A.
  • Ticker: MRC
  • Exchange: WSE
  • Founded: 1989
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Market Cap: zł73.277m
  • Shares outstanding: 10.59m
  • Website: https://mercatormedical.eu

Location

  • Mercator Medical S.A.
  • Ul. H. Modrzejewskiej 30
  • Kraków
  • 31-327
  • Poland

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
MRCWSE (Warsaw Stock Exchange)YesBearer SharesPLPLNJan 2014

Biography

Mercator Medical S.A., together with its subsidiaries, produces medical gloves and distributes medical disposables in Europe and Russia. The company offers surgical gloves for conducting invasive surgeries ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/22 21:30
End of Day Share Price2019/10/22 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.